Mark J. Levis, MD, PhD¹, Mehdi Hamadani, MD², Brent R. Logan, PhD^3*, Richard J. Jones, MD⁴, Anurag K. Singh, MD⁵, Mark R. Litzow, MD⁶, John R. Wingard, MD⁷, Esperanza B. Papadopoulos, MD⁸, Alexander Perl⁹, Robert J. Soiffer, MD¹⁰, Celalettin Ustun, MD¹¹, Masumi Ueda Oshima, MD¹², Geoffrey L Uy, MD¹³, Edmund K. Waller, MD¹⁴, Sumithira Vasu, MD, MBBS¹⁵, Melhem M. Solh, MD¹⁶, Asmita Mishra, MD, MBA¹⁷, Lori S. Muffly, MD¹⁸, Hee-Je Kim^19*, Matthias Stelljes, MD²⁰, Yuho Najima, MD, PhD²¹, Masahiro Onozawa, M.D., Ph.D.²², Kirsty Thomson, MB ChB^23*, Arnon Nagler, MD, M.Sc^24*, Andrew H. Wei, MBBS, PhD²⁵, Guido Marcucci, MD²⁶, Nahla Hasabou, MD^27*, Mathew Rosales, PhD^27*, Jason Hill, PhD^27*, Stanley C. Gill, PhD^27*, Rishita Nuthethi, PhD^27*, Denise King, MS, CCRA^28*, Heather Wittsack, MPH^28*, Adam Mendizabel, PhD^28*, Steven M. Devine, MD²⁹, Mary M. Horowitz, MD³⁰ and Yi-Bin Chen, MD, MS³¹

¹Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, MD
²Division of Hematology and Oncology, The Medical College of Wisconsin Inc, Milwaukee, WI
³Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
⁴Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD
⁵University of Kansas Medical Center, Westwood, KS
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷University of Florida Division of Hematology/Oncology, Gainesville, FL
⁸Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
¹⁰Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹¹Rush University Medical Center, Chicago, IL
¹²University Hospitals Case Medical Center, Seattle, WA
¹³Division of Oncology, Washington University School of Medicine, Saint Louis, MO
¹⁴Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
¹⁵Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
¹⁶Northside Hospital, Atlanta, GA
¹⁷Moffitt Cancer Center, Tampa, FL
¹⁸Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
¹⁹Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Seoul, Korea, Republic of (South)
²⁰Department of Internal Medicine A, University of Muenster, Muenster, Germany
²¹Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, TKY, Japan
²²Department of Hematology, Hokkaido University Hospital, Sapporo, Japan
²³UCLH, London, GBR
²⁴Hematology and Bone Marrow Transplantation Division, Chaim Sheba Medical Center,, Tel-Hashomer, Israel
²⁵Peter Maccallum Cancer Centre, Melbourne, VIC, Australia
²⁶Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA
²⁷Astellas Pharma Global Development, Northbrook, IL
²⁸The Emmes Corporation, Rockville, MD
²⁹Be the Match Foundation, Minneapolis, MN
³⁰Center for International Blood and Marrow Transplant Research, Milwaukee, WI
³¹Massachusetts General Hospital, Boston, MA

Adrian Mosquera Orgueira, MD, PhD^1*, Manuel Perez Encinas^2*, Jose Angel Diaz Arias^3*, Rebeca Rodriguez Veiga, MD^4*, Juan Miguel Bergua Burgues^5*, Jesús Lorenzo Algarra^6*, Carmen Botella^7*, Jose Antonio Perez Simon^8*, Teresa Bernal^9*, Mar Tormo, M.D.¹⁰, Maria Calbacho^11*, Olga Salamero, MD^12*, Josefina Serrano, MD^13*, Victor Noriega^14*, Juan Antonio Lopez Lopez^15*, Susana Vives^16*, Mercedes Colorado^17*, Jose Luis Lopez Lorenzo, MD^18*, Maria Vidriales Vicente^19*, Raimundo Garcia Boyero^20*, Maria Teresa Olave Rubio^21*, Pilar Herrera Puente^22*, Olga Arce^23*, Manuel Barrios Garcia^24*, Maria Jose Sayas Lloris^25*, Marta Polo^26*, Maria Isabel Gomez Roncero^27*, Eva Barragan, PhD^28*, Rosa Ayala, MD, PhD^29*, Carmen Chillon^30*, Maria Jose Calasanz, PhD^31*, Blanca Boluda^32*, Andres Peleteiro Raindo^33*, Raquel Amigo^34*, David Martinez Cuadron^35*, Jorge Labrador^36* and Pau Montesinos, PhD, MD^37*

¹University Hospital of Santiago de Compostela, Department of Hematology, IDIS, SANTIAGO DE COMPOSTELA, Spain
²University Hospital of Santiago de Compostela, Department of Hematology, IDIS, SANTIAGO, ESP
³University Hospital of Santiago de Compostela, Department of Hematology, IDIS, A Coruña, Spain
⁴Hospital Universitary i Politecnic La Fe, VALENCIA, ESP
⁵Hospital San Pedro de Alcántara, Cáceres, Spain
⁶Hospital General de Albacete, Albacete, ESP
⁷Hospital General Universitario de Alicante, Alicante, Spain
⁸University Hospital Virgen del Rocío, Sevilla, Spain
⁹Hospital Universitario Central De Asturias, Oviedo, ESP
¹⁰Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain
¹¹Hospital Universitario 12 de Octubre, Madrid, Spain
¹²Hospital Vall d'Hebron, Barcelona, Barcelona, ESP
¹³Hospital Universitario Reina Sofía, IMIBIC, Cordoba, ESP
¹⁴Hospital Clínico de A Coruña, A Coruña, Spain
¹⁵Hospital Universitario de Jaen, Jaen, Spain
¹⁶Hospital Germans Trias i Pujol, Badalona, ESP
¹⁷Hospital Universitario Marqués De Valdecilla, Santander, Spain
¹⁸Fundacion Jimenez Diaz, Madrid, ESP
¹⁹Hospital Universitario de Salamanca, IBSAL, CIBER-ONC number CB16/12/00233 y Centro de Investigación, Salamanca, Spain
²⁰Hospital General Universitario de Castellon, Castellon, Spain
²¹Hospital Clinico Universitario Lorenzo Blesa, Zaragoza, ESP
²²Hospital Universitario Ramon y Cajal, Madrid, ESP
²³Hospital Universitario de Basurto, Bilbao, Spain
²⁴Hospital Universitario Regional de Malaga, Malaga, Spain
²⁵Hospital Dr. Peset, ZARAGOZA, ESP
²⁶Hospital Clinico San Carlos, Madrid, Ma, ESP
²⁷Hospital Virgen de la Salud, Toledo, Spain
²⁸Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
²⁹Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC, Madrid, Spain
³⁰Hospital Universitario de Salamanca; (CIC, IBMCC USAL-CSIC), Salamanca, ESP
³¹Cancer Center Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain
³²Hospital Universitari I Politècnic La Fe, Valencia, ESP
³³University Hospital of Santiago De Compostela, Department of Hematology, IDIS, SANTIAGO DE COMPOSTELA, ESP
³⁴Instituto de Investigaciones Santiarias La Fe, Valencia, Spain
³⁵Hospital Universitari i Politecnic La Fe, Valencia, Spain
³⁶Hospital Universitario de Burgos, Universidad Isabel I, Burgos, ESP
³⁷Hospital Universitari i Politecnic la Fe, Valencia, Spain

Pierre Peterlin^1*, Joëlle Gaschet, PhD^2*, Sarah Bertoli^3*, Marc Bernard, MD^4*, Martin Carre, MD^5*, Pierre-Yves Dumas, MD, PhD^6*, Mathilde Hunault, MD, PhD^7*, Amine Belhabri, MD^8*, Anne Banos, MD^9*, Caroline Bonmati, MD^10*, Emmanuelle Tavernier, MD^11*, Gaelle Guillerm^12*, Sarah Bonnet, MD^13*, Justine Decroocq, MD^14*, Alain Saad, MD^15*, Mario Ojeda-Uribe, MD^16*, Romain Guieze, MD, PhD^17*, Tony Marchand, MD, PhD^18*, Christian Recher, MD, PhD^3*, Alice Garnier, MD^19*, Marie-Anne Vibet, PhD^20* and Patrice Chevallier, MD¹

¹Nantes University Hospital, Nantes, France
²CRCI2NA UMR INSERM 1307 CNRS 6075 - Nantes Université - Université d'Angers, France, NANTES, France
³Service d'Hématologie, Centre Hospitalo-universitaire de Toulouse, Centre de Recherches en Cancérologie de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Université de Toulouse, UPS, INSERM, CNRS, Toulouse, France, Toulouse, France
⁴Clinical Hematology Department, Rennes University Hospital, Rennes, France, Rennes, FRA
⁵Clinical Hematology Department, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France
⁶CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, F-33000 Bordeaux, France;BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, Univ. Bordeaux, F-33000 Bordeaux, France, Bordeaux, France
⁷HOTEL DIEU, ANGERS CEDEX 9, France
⁸Centre Leon Berard, Lyon, FRA
⁹Centre Hospitalier De Bayonne, Bayonne, FRA
¹⁰Service D'Hématologie, Centre Hospitalier Universitaire De Nancy, Nancy, FRA
¹¹Institut De Cancérologie De La Loire, Saint Priest En Jarez, FRA
¹²Service d'hématologie, Hôpital Morvan, CHRU Brest, Brest, France
¹³Clinical Hematology Department, Montpellier University Hospital, Montpellier, France, montpellier, France
¹⁴Clinical Hematology Department, Hopital Cochin, APHP, Paris, France, Paris, France
¹⁵Clinical Hematology Department, Bezier Hospital, Beziers, France, Beziers, FRA
¹⁶Clinical Hematology Department, Mulhouse Hospital, Mulhouse, France, Mulhouse, FRA
¹⁷CHU Estaing, Clermont Ferrand, FRA
¹⁸Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
¹⁹Hematology clinic, Nantes University Hospital, Nantes, France
²⁰Clinical Research Centre, University Hospital of Nantes, Nantes, France

Romane Joudinaud^1*, Augustin Boudry^2*, Laurène Fenwarth, MD, MSc^2*, Sandrine Geffroy^3*, Mikaël Salson^4*, Herve Dombret, MD⁵, Céline Berthon, MD^6*, Arnaud Pigneux, MD, PhD^7*, Delphine Lebon^8*, Lamya Haddaoui^9*, Raphael Itzykson, M.D. / Ph.D.¹⁰, Christian Recher, MD, PhD^11*, Audrey Bidet, MD^12*, Eric Delabesse, MD, PhD^13*, Mathilde Hunault, MD^14*, Claude Preudhomme, PharmD, PhD^15*, Nicolas Duployez, PharmD, PhD^15* and Pierre-Yves Dumas, MD, PhD^16*

¹UMR9020-U1277-CANTHER, Lille, France
²Hematology Laboratory, CHU Lille, Lille, France
³CHU Lille, Lille, FRA
⁴Cristal (UMR CNRS 9189, Univ Lille), Inria, Villeneuve D'Ascq, FRA
⁵Saint Louis Hospital, University of Paris, Paris, France
⁶Hematology Department, CHRU Lille, Lille, France
⁷Hématologie Clinique et Thérapie cellulaire, CHU Bordeaux, Bordeaux, France
⁸Université Picardie Jules Verne, Amiens, FRA
⁹FILO, Paris, France
¹⁰Hematology Department, Saint-Louis Hospital AP-HP Paris France, Paris, France
¹¹Hematology Department, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
¹²Laboratoire d’Hématologie Biologique, CHU Bordeaux, Bordeaux, France
¹³IUCT-Oncopole, Hematology Laboratory, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
¹⁴HOTEL DIEU, ANGERS CEDEX 9, FRA
¹⁵Laboratory of Hematology, Centre Hospitalier Universitaire (CHU) Lille, Lille, France
¹⁶CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, F-33000 Bordeaux, France;BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, Univ. Bordeaux, F-33000 Bordeaux, France, Bordeaux, France

Shai Shimony, MD^1,2*, Jacqueline S. Garcia, MD¹, Julia Keating, MS^3*, Evan C. Chen, MD⁴, Marlise R. Luskin, MD⁵, Maximilian Stahl, MD⁶, Donna S. Neuberg, ScD³, Daniel J. DeAngelo⁷, Richard M Stone, MD⁷ and R. Coleman Lindsley⁸

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Department of Hematology, Rabin Medical Center, Tel Aviv Faculty of Medicine, Tel Aviv, Israel
³Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁴Medical Oncology, Dana Farber Cancer Institute, Boston, MA
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁶Dana Farber Institute, Boston, MA
⁷Dana-Farber Cancer Institute, Boston, MA
⁸Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA

Curtis A. Lachowiez, MD¹, Christopher A. Eide^1*, Stephen E. Kurtz^1*, Nicola Long^1*, Manoj Rai, MD^2*, Wei Xie, MD, PhD^3*, Andy Kaempf, MS^4*, Daniel Bottomly^1*, Rachel J. Cook, MD⁵, Gabrielle Meyers, MD^1*, Arpita Gandhi, MD⁶, Jessica T. Leonard, MD⁷, Brandon Hayes-Lattin, MD⁸, Laura F. Newell, MD¹, Richard T Maziarz, MD¹, Jennifer N. Saultz, DO⁹, Elie Traer, MD, PhD¹⁰, Theodore P Braun, MD, PhD¹, Ronan T. Swords, MD, PhD, FRCP, FRCPath¹¹, Shannon K McWeeney, PhD^1* and Jeffrey W Tyner, PhD¹

¹Knight Cancer Institute, Oregon Health & Science University, Portland, OR
²Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Sciences University, Portland, OR
³Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR
⁴Department of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR
⁵Oregon Health and Science University, Portland, OR
⁶Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR
⁷Department of Hematology & Medical Oncology, Oregon Health and Science University, Portland, OR
⁸Knight Cancer Institute, Oregon Health Science University, Portland, OR
⁹Oregon Health & Science University, Portland, OR
¹⁰Knight Cancer Institute, Oregon Health & Sciences University, Portland, OR
¹¹Knight Cancer Institute, Oregon Health and Science University, Portland, OR